🚀 Queue: Bottle In, Prescription Out
$18.6M to drop a fully autonomous robotic pharmacy wherever patients need one.
Walk up, scan a QR code, and about 60 seconds later your prescription drops out — counted, labeled, and verified, with no pharmacist behind the counter. That's the machine Queue just came out of stealth with $18.6M to build. Let's check them out!
⚾️ The Elevator Pitch
Nearly one in three U.S. pharmacies has closed since 2010, stranding roughly 50 million Americans in "pharmacy deserts" with nowhere convenient to fill a script. The counters still open are buckling: pharmacy schools are on track to graduate 3,000–4,000 fewer pharmacists than the country needs over the next five to six years, and technician vacancies run as high as 40%. Worse, the scarce experts spend their days on mechanical work — counting pills, printing labels, double-checking the vial — instead of with patients.
Enter Queue, a Palo Alto startup building what it calls the world's first fully autonomous robotic pharmacy. Its "Queue Unit" takes sealed wholesale bottles in one end and pushes filled, verified prescription vials out the other — no on-site pharmacist required — covering the ~250 most-prescribed U.S. medications, filling a script in under a minute, and running around the clock. Founders Nick Desai (CEO, who earlier built house-call startup Heal to $200M+ raised) and Josh Liu (CTO, ex-Tesla, Zipline, and Waymo) just brought it out of stealth with an $18.6M haul — a $12.6M seed led by AlleyCorp on top of a $6M Riot Ventures pre-seed. Queue says the unit dispenses at up to 96% lower cost, and it's already signed a major national pharmacy chain.
👇 The Drop Down
🌐 Website: queue.inc
🏷️ Launched: Out of stealth, June 2026
👥 Founders: Nick Desai (CEO), Josh Liu (CTO)
💰 Stage: Seed — $18.6M total ($12.6M seed led by AlleyCorp + $6M pre-seed led by Riot Ventures; House Capital, Ubiquity Ventures, Grep Ventures & Banter Capital joining)
📈 Traction: Working prototype deployed; one major national pharmacy chain signed; wide-scale rollout targeted for ~January 2027
🔮 Tech Trend: Physical AI / healthcare automation
🎯 Target Market: Retail pharmacy chains, hospitals, and rural / pharmacy-desert communities
🏢 Location: Palo Alto, CA (~20-person team)
🔎 Why We Like It
📈 The crisis is the tailwind: Automating a pharmacy used to be a nice-to-have; now it's survival. With a third of U.S. pharmacies gone since 2010 and chains bleeding on reimbursements, a unit that fills scripts at a fraction of the cost lands exactly when the industry needs it. The pharmacy-automation market is projected to grow from $6.23B in 2023 to $10.0B by 2030 (7.1% CAGR) — and that's the equipment slice of a ~$670B U.S. retail-pharmacy market Queue is ultimately aiming at.
🤖 It removes the pharmacist from the wrong job, not the right one: Incumbents like Omnicell and Amazon Pharmacy speed up a pharmacy that still needs a licensed pharmacist standing in it. Queue's whole-machine bet is different — the Queue Unit counts, labels, and computer-vision-verifies on its own, so it can go where you can't staff a pharmacy at all. As CTO Josh Liu puts it, they're taking "the work off their plate that never needed a human," letting pharmacists get back to counseling patients.
👫 Founders who actually ship hardware: Desai is a six-time founder who scaled Heal into millions of house calls, while Liu ran engineering on flying blood-delivery drones at Zipline and hardware at Tesla. Their ~20-person team pulls from Rivian, Waymo, and aerospace — exactly the people who know how to make a physical machine hit 100% reliability, which is the only bar a pharmacy can pass.
The challenge will be the regulators. Most state pharmacy boards still require a licensed pharmacist to verify the final fill — often allowed remotely, but roughly 22 states restrict or don't clearly authorize telepharmacy at all, so a national rollout means 50 separate compliance regimes. DEA rules also keep controlled substances (a big slice of scripts) off an autonomous kiosk for now, and well-capitalized incumbents like Omnicell and Amazon keep a pharmacist in the loop and won't cede the counter quietly. "Fully autonomous" has to survive contact with all three.
🤝 Get Involved with Queue
📱 See the Queue Unit — the fully autonomous pharmacy up close
💼 Join the team — hiring across robotics, hardware, software & pharmacy ops in Palo Alto
📰 Read the launch story on The Robot Report
🧠 Read Ubiquity Ventures' thesis on why they backed Queue
Reducing the friction for patient adherence has been one of the longest standing issues over the years and Queue is taking one massive step in solving that issue!